Isidore Faiferman

1.9k total citations · 1 hit paper
26 papers, 1.5k citations indexed

About

Isidore Faiferman is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Isidore Faiferman has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Physiology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Isidore Faiferman's work include Asthma and respiratory diseases (8 papers), Respiratory and Cough-Related Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Isidore Faiferman is often cited by papers focused on Asthma and respiratory diseases (8 papers), Respiratory and Cough-Related Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Isidore Faiferman collaborates with scholars based in United States, United Kingdom and Belgium. Isidore Faiferman's co-authors include David Koffler, J B Winfield, William W. Busse, A.O. Pogo, John G. Matthews, Patrick Flood-Page, Douglas S. Robinson, Sally E. Wenzel, Cheri A. Swenson and Trevor T. Hansel and has published in prestigious journals such as Journal of Clinical Investigation, JNCI Journal of the National Cancer Institute and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Isidore Faiferman

25 papers receiving 1.4k citations

Hit Papers

A Study to Evaluate Safety and Efficacy of Mepolizumab in... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isidore Faiferman United States 14 776 536 472 303 264 26 1.5k
Peter Rosenthal United States 23 715 0.9× 342 0.6× 994 2.1× 155 0.5× 521 2.0× 37 2.0k
Anne Bordron France 23 192 0.2× 139 0.3× 527 1.1× 244 0.8× 311 1.2× 51 1.4k
Nathan Schoettler United States 11 392 0.5× 154 0.3× 292 0.6× 74 0.2× 165 0.6× 18 753
Patricia J. Baker United States 23 146 0.2× 184 0.3× 856 1.8× 90 0.3× 263 1.0× 35 1.5k
Dana P. Ascherman United States 28 449 0.6× 920 1.7× 421 0.9× 828 2.7× 653 2.5× 78 2.4k
Sylvie Abi-Younes United States 9 348 0.4× 137 0.3× 386 0.8× 71 0.2× 118 0.4× 9 969
Seishi Harada Japan 13 100 0.1× 130 0.2× 333 0.7× 312 1.0× 164 0.6× 26 932
Tsan‐Teng Ou Taiwan 16 142 0.2× 89 0.2× 409 0.9× 344 1.1× 246 0.9× 59 997
T Akabane Japan 18 173 0.2× 72 0.1× 531 1.1× 51 0.2× 245 0.9× 87 1.1k
Eva Wex Germany 9 233 0.3× 635 1.2× 112 0.2× 94 0.3× 186 0.7× 10 904

Countries citing papers authored by Isidore Faiferman

Since Specialization
Citations

This map shows the geographic impact of Isidore Faiferman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isidore Faiferman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isidore Faiferman more than expected).

Fields of papers citing papers by Isidore Faiferman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isidore Faiferman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isidore Faiferman. The network helps show where Isidore Faiferman may publish in the future.

Co-authorship network of co-authors of Isidore Faiferman

This figure shows the co-authorship network connecting the top 25 collaborators of Isidore Faiferman. A scholar is included among the top collaborators of Isidore Faiferman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isidore Faiferman. Isidore Faiferman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flood-Page, Patrick, Cheri A. Swenson, Isidore Faiferman, et al.. (2007). A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma. American Journal of Respiratory and Critical Care Medicine. 176(11). 1062–1071. 550 indexed citations breakdown →
2.
Borrill, Zöe, Catherine M. Houghton, Ruth Tal‐Singer, et al.. (2007). The use of plethysmography and oscillometry to compare long‐acting bronchodilators in patients with COPD. British Journal of Clinical Pharmacology. 65(2). 244–252. 62 indexed citations
3.
Pauwels, Romain, Guy Joos, Charles Fogarty, et al.. (2007). Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD. Pulmonary Pharmacology & Therapeutics. 21(2). 385–392.
4.
Singh, Dave, Ruth Tal‐Singer, Isidore Faiferman, et al.. (2006). Plethysmography and impulse oscillometry assessment of tiotropium and ipratropium bromide; a randomized, double‐blind, placebo‐controlled, cross‐over study in healthy subjects. British Journal of Clinical Pharmacology. 61(4). 398–404. 16 indexed citations
5.
Hamilton, Allan J., et al.. (1998). Asthma, rhinitis, other respiratory diseases Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen- induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. 1 indexed citations
6.
Hamilton, Allan J., et al.. (1998). Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. Journal of Allergy and Clinical Immunology. 102(2). 177–183. 106 indexed citations
7.
Grossman, Jay, Isidore Faiferman, Jeffrey W. Dubb, et al.. (1997). Results of the First U.S. Double-Blind, Placebo-Controlled, Multicenter Clinical Study in Asthma with Pranlukast, a Novel Leukotriene Receptor Antagonist. Journal of Asthma. 34(4). 321–328. 70 indexed citations
8.
Bernstein, Jonathan A., David I. Bernstein, Jeffrey W. Dubb, Isidore Faiferman, & Bruce A. Wallin. (1996). A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Journal of Allergy and Clinical Immunology. 98(2). 317–324. 55 indexed citations
9.
Torphy, Theodore J., Isidore Faiferman, John G. Gleason, et al.. (1991). The Preclinical and Clinical Pharmacology of SK&F 104353, a Potent and Selective Peptidoleukotriene Receptor Antagonist. Annals of the New York Academy of Sciences. 629(1). 157–167. 10 indexed citations
10.
Faiferman, Isidore & David Koffler. (1982). Staphylococcal protein a fluoroimmunoassay for immune complexes. Arthritis & Rheumatism. 25(7). 799–801. 1 indexed citations
11.
Ghosh, Luna, et al.. (1981). Ultrastructural study of membrane glycocalyx in primary and metastatic human and rat mammary carcinoma. Journal of Surgical Oncology. 17(4). 395–401. 3 indexed citations
12.
Ghosh, Luna, et al.. (1981). Pathology of metastasizing tumors in nitrosomethyl urea‐induced rat mammary carcinoma. Journal of Surgical Oncology. 18(1). 21–26. 1 indexed citations
13.
Nerenberg, S. T., et al.. (1980). Isolation and characterization of a human liver and kidney-specific protein: the hepato-renal (H-R) antigen.. PubMed. 39(3). 626–34. 4 indexed citations
14.
Nerenberg, S. T., et al.. (1980). Isolation and characterization of a human pancreas-specific protein.. Clinical Chemistry. 26(2). 209–213. 5 indexed citations
15.
Faiferman, Isidore, et al.. (1980). Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.. PubMed. 55(6). 728–31. 11 indexed citations
16.
Winfield, J B, Isidore Faiferman, & David Koffler. (1977). Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.. Journal of Clinical Investigation. 59(1). 90–96. 340 indexed citations
17.
Faiferman, Isidore, A.O. Pogo, Jerome Schwartz, & M. Edward Kaighn. (1973). Isolation and characterization of membrane-bound polysomes from ascites tumor cells. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 312(3). 492–501. 27 indexed citations
18.
Faiferman, Isidore, et al.. (1973). Polyadenylic acid sequences in ascites cells nuclear particles and membrane-bound messenger RNA. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 294(3). 541–546. 13 indexed citations
19.
Faiferman, Isidore, Mary G. Hamilton, & A.O. Pogo. (1971). Nucleoplasmic ribonucleoprotein particles of rat liver. II. Physical properties and action of dissociating agents.. PubMed. 232(4). 685–96. 57 indexed citations
20.
Faiferman, Isidore, Mary G. Hamilton, & A.O. Pogo. (1970). Nucleoplasmic ribonucleoprotein particles of rat liver. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 204(2). 550–563. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026